Protocol - Health Quality Index for Economic Evaluations - Adult
The EQ-5D-3L is a standardized instrument for use as a measure of health outcomes. The EQ-5D-3L is applicable to a wide range of health conditions and treatments; it provides a simple descriptive profile and a single index value for health status. This instrument offers three levels of answers: no problems, some problems, or extreme problems.
The EQ-5D-3L self-reported questionnaire includes a descriptive system and the EQ visual analogue scale (EQ VAS). The descriptive system comprises five dimensions:
- Usual Activities
Each dimension has three levels:
- No problems
- Moderate problems
- Extreme problems
For the descriptive system, the respondent is asked to indicate his or her health state by marking the most appropriate statement in each of the three dimensions. This decision results in a one-digit number expressing the level selected for that dimension. The digits for three dimensions can be combined in a three-digit number describing the respondent’s health state.
The visual analogue scale records the respondent’s self-rated health on a 20 cm vertical, visual analogue scale with endpoints labeled "the best health you can imagine" and "the worst health you can imagine." This information can be used as a quantitative measure of health, as judged by the individual respondents.
EQ-5D™ is a trademark of the EuroQol Group.
Protocol Name from Source:
Personnel and Training Required
|Specialized requirements for biospecimen collection||No|
|Average time of greater than 15 minutes in an unaffected individual||No|
Mode of Administration
Adults aged 18 years or older
Note: Licensing fees are determined by the EuroQol Executive Office on the basis of the user information provided on the registration form. The amount is dependent on the type of study, funding source, sample size, and number of requested languages. You are not obligated to purchase by registering.
See EQ-5D-3L User Guide for instructions and scoring.
The EQ-5D-3L is used in clinical and economic evaluations of health care and also in population health surveys. The instrument has multinational and national usages. It is available in multiple modalities (face-to-face, online, tablet, paper, etc.). It is being applied in multinational trials by pharmaceutical companies.
English, English, Available in other languages, Available in other languages
|Common Data Elements (CDE)||Adult Health Quality Index Assessment Score||3373530||CDE Browser|
Process and Review
The Expert Review Panel #3 (ERP 3) reviewed the measures in Alcohol, Tobacco and Other Substances, and Substance Abuse and Addiction domains.
Guidance from ERP 3 includes:
• Changed name of Measure
• Updated protocol
• New Data Dictionary
Back-compatible: Partially back-compatible (updated/similar protocol which would require some changes to the data dictionary), variable mapping between current and previous protocols can be found here
Previous version in Toolkit archive (link)
EuroQol Group. (2005). EQ-5D. Rotterdam, Netherlands: Author.
The EQ-5D can be obtained by contacting the following: EuroQol Group Executive Office Marten Meesweg 107 3068 AV Rotterdam Netherlands Telephone: +31 884400190 E-mail: firstname.lastname@example.org
Bridges, J. (2003). Stated preference methods in health care evaluation: An emerging methodological paradigm in health economics. Applied Health Economics and Health Policy, 2(4), 213-224.
Brooks, R., Rabin, R., & de Charro, F. (Eds). (2003). The measurement and valuation of health status using EQ-5D: A European perspective. Dordrecht, Netherlands: Kluwer Academic.
Devlin, N. J., Hansen, P., Kind, P., & Williams, A. (2003). Logical inconsistencies in survey respondents’ health state valuations-A methodological challenge for estimating social tariffs. Health Economics, 12(7), 529-544.
Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical Care, 35(11), 1095-1108.
Dolan, P. (1999). Whose preferences count? Medical Decision Making, 19(4), 482-486.
Greiner, W., Weijnen, T., Nieuwenhuizen, M., Oppe, S., Badia, X., Busschbach, J., Buxton, M., Dolan, P., Kind, P., Krabbe, P., Ohinmaa, A., Parkin, D., Roset, M., Sintonen, H., Tsuchiya, A., & de Charo, F. (2003). A single European currency for EQ-5D health states. Results from a six-country study. European Journal of Health Economics, 4(3), 222-231.
Kind, P. (2003). Guidelines for value sets in economic and non-economic studies using EQ-5D. In R. Brooks, R. Rabin, & F. de Charro (Eds.), The measurement and valuation of health status using EQ-5D: A European perspective (pp. 29-42). Dordrecht, Netherlands: Kluwer.
Shaw, J. W., Johnson, J. A., & Coons, S. J. (2005). US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care, 43(3), 203-220.
Agency for Healthcare Research and Quality. (2012 January). U.S. validation of the EuroQol EQ-5D™ Health States.. Rockville, MD: Author.
|Variable Name||Variable ID||Variable Description||Version||dbGaP Mapping|
Health Quality Index for Economic Evaluations
November 21, 2016
Instrument used to measure respondent’s quality of life, given medical conditions or health problems.
The purpose of this measure is to construct a quality-adjusted life year index that can be used to assess the relative burden of living with any given medical condition, including substance abuse addiction and other chronic conditions.
Adolescent health, Anxiety, Child health, Depression, Discomfort, Feelings, EQ-5D, EQ-5D-Y, EuroQol Group, Health status, HRQOL, Measurement, Mobility, Pain, Quality of life, Self-care, Usual activities, VAS, Visual analogue scale, SAA, Substance Use-related Co-morbidities and Health-related Outcomes